Wellbutrin SR is an aminoketone antidepressant indicated for the treatment of major depressive disorder (MDD). Bupropion HCl is presumed to exert its effects through noradrenergic and/or dopaminergic mechanisms. Bupropion is a relatively weak inhibitor of the neuronal reuptake of norepinephrine and dopamine, and does not inhibit the reuptake of serotonin; it does not inhibit monoamine oxidase.
Bupropion HCl Extended-Release Tablets are available as 100mg, 150mg, and 200mg strengths in 60-, 100-, and 500-count bottles.
For more information call (866) 733-3952 or visit DrReddys.com.